Aim: The study was aimed to investigate the safety of the transrectal ultrasound-guided
prostate needle biopsy in the elderly.
Material-method: Five hundered fifteen patients, who underwent prostate biopsy
between 2017-2020, were included in the study. All patients' demographic data,
comorbidities, laboratory findings, prostate volumes, prostate biopsy pathology results,
and post-biopsy complications were retrospectively analyzed. The patients were divided
into 2 groups: group-1 consisting of patients under the age of 65 and group-2 with above
the age of 65.
Results: There were 244 in group-1 and 271 patients in group-2. The mean age of
group-1 was 59.50±3.98, group-2 was 71.45±4.57 years. In group-1, post-biopsy fever
was observed in 5 (2%), hematuria in 44 (18%), hemospermia in 79 (32.4%), and rectal
bleeding in 7 (2.9%) patients. In group-2, post-biopsy fever was observed in 15 (5.5%),
hematuria in 69 (25.5%), hemospermia in 21 (7.7%), and rectal bleeding in 11 (4.1%)
patients. The severe sepsis findings were observed in 2 patients (0.2%) in group-1 and 6
(2.2%) in group-2. In the logistic-regression-analysis, it was determined that the risk of
complication increased significantly as the age, PSA, and higher PSA density.
Conclusion: In our study, it was revealed that the risk of complications was higher in the
elderly and that the complications observed may be more seriously. Therefore, we
consider that a more careful approach should be taken in elderly patients to prevent the
complications related with prostate biopsy.